Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trial
- Ke Liu
- Bao-Dong Qin
- Shi-Qi Chen
- Xue Zhong
- Xiao-Peng Duan
- Ying Wu
- Zhan Wang
- Yan Ling
- Li Sun
- Chen-Yang Ye
- Dong-Min Shi
- Ning Gao
- Xiao-Dong Jiao
- Yuan-Sheng Zang
2025-05-31